Literature DB >> 15287025

Alternative mechanisms of gene amplification in human cancers.

Yoshitaka Kuwahara1, Chikako Tanabe, Tatsuro Ikeuchi, Kazuhiko Aoyagi, Michiko Nishigaki, Hiromi Sakamoto, Kiyotaka Hoshinaga, Teruhiko Yoshida, Hiroki Sasaki, Masaaki Terada.   

Abstract

Gene amplification is a common phenomenon in cancer. Cytogenetic analyses have indicated that breakage-fusion-bridge (BFB) cycles drive intrachromosomal amplification of some oncogenes in a head-to-head manner in human cancers. However, the complex structures of an amplified sequence found in cancers are not always explained by the BFB model. At the 17q21 locus, which is not linked to common fragile sites, we discovered a recombination hot spot harboring amplicon repeats in tandem in a head-to-tail orientation, with the interamplicon junctions in each cancer cell being homogeneous. These findings clearly show the presence of alternative mechanisms other than BFB cycles in oncogene amplification. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287025     DOI: 10.1002/gcc.20075

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.

Authors:  Graham R Bignell; Thomas Santarius; Jessica C M Pole; Adam P Butler; Janet Perry; Erin Pleasance; Chris Greenman; Andrew Menzies; Sheila Taylor; Sarah Edkins; Peter Campbell; Michael Quail; Bob Plumb; Lucy Matthews; Kirsten McLay; Paul A W Edwards; Jane Rogers; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Genome Res       Date:  2007-08-03       Impact factor: 9.043

Review 2.  Palindromic gene amplification--an evolutionarily conserved role for DNA inverted repeats in the genome.

Authors:  Hisashi Tanaka; Meng-Chao Yao
Journal:  Nat Rev Cancer       Date:  2009-02-12       Impact factor: 60.716

3.  Aberrations of ERBB2 and TOP2A genes in breast cancer.

Authors:  Kirsten Vang Nielsen; Sven Müller; Susanne Møller; Andreas Schønau; Eva Balslev; Ann S Knoop; Bent Ejlertsen
Journal:  Mol Oncol       Date:  2009-11-18       Impact factor: 6.603

4.  HER-2/neu gene amplification in gastric adenocarcinoma and its relationship with clinical and pathological findings.

Authors:  Ramin Azarhoosh; Rokhsare Ebneghasem; Sima Besharat
Journal:  J Gastrointest Oncol       Date:  2017-12

5.  Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.

Authors:  Pierre-Jean Lamy; Frédéric Fina; Caroline Bascoul-Mollevi; Anne-Claire Laberenne; Pierre-Marie Martin; L'Houcine Ouafik; William Jacot
Journal:  Breast Cancer Res       Date:  2011-02-02       Impact factor: 6.466

6.  Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.

Authors:  Qiong Wu; Michèle J Hoffmann; Florian H Hartmann; Wolfgang A Schulz
Journal:  Mol Cancer       Date:  2005-05-05       Impact factor: 27.401

7.  How a replication origin and matrix attachment region accelerate gene amplification under replication stress in mammalian cells.

Authors:  Shun-suke Tanaka; Sho-hei Mitsuda; Noriaki Shimizu
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

8.  Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.

Authors:  Rebecca F Lowdon; Ting Wang
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

9.  Single-stranded annealing induced by re-initiation of replication origins provides a novel and efficient mechanism for generating copy number expansion via non-allelic homologous recombination.

Authors:  Kenneth J Finn; Joachim J Li
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

10.  Regulatory mechanisms that prevent re-initiation of DNA replication can be locally modulated at origins by nearby sequence elements.

Authors:  Christopher D Richardson; Joachim J Li
Journal:  PLoS Genet       Date:  2014-06-19       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.